OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 134 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $408,000 | -57.4% | 193,408 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $957,000 | -56.9% | 193,408 | -31.8% | 0.00% | -50.0% |
| Q1 2015 | $2,219,000 | +51.8% | 283,408 | +17.5% | 0.00% | 0.0% |
| Q4 2014 | $1,462,000 | +42.2% | 241,200 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $1,028,000 | -37.2% | 241,200 | -9.0% | 0.00% | -50.0% |
| Q2 2014 | $1,638,000 | – | 265,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,250,000 | $8,125,000 | 5.71% |
| Rock Springs Capital Management LP | 830,000 | $5,395,000 | 1.24% |
| First Light Asset Management, LLC | 195,359 | $1,270,000 | 0.90% |
| Palo Alto Investors LP | 3,338,048 | $21,698,000 | 0.90% |
| Rhenman & Partners Asset Management AB | 329,199 | $2,140,000 | 0.64% |
| NEA Management Company, LLC | 1,935,300 | $12,579,000 | 0.62% |
| PFM Health Sciences, LP | 5,129,129 | $33,339,000 | 0.60% |
| Sivik Global Healthcare LLC | 124,145 | $807,000 | 0.50% |
| QVT Financial LP | 1,322,729 | $8,598,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 433,657 | $2,819,000 | 0.41% |